The Pharmaceuticals Market in Serbia from production to sales
25. November 2009. 9:00 - 16:00
Serbia, Hyatt Regency Hotel
Organiser: Ekonom:east Media Group
Does the crisis influence the pharmaceutical products market and to what extent? What is the price policy in the market? Should the legislation be changed in order to make the pharmaceutical industry more successful, and in what direction? In what way are these problems solved in the region? These are the main topics of the THIRD traditional conference organized by EMG. These and many other issues related to the pharmaceutical sector – from production to sale, will be discussed by eminent experts in this field in three panels, after an introductory speech of Minister of Health, Mr. Tomica Milosavljevic.
· The pharmaceutical products marketed (manufacturer, distributer, retail) in Serbia vs. the region
· Further consolidation of the market for the benefit of customers – manufacturers, wholesalers or pharmacies?
· The role of marketing in pharmacy (where are the borders,..)
· The role of wholesale in marketing medications –only a distribution channel or support for the marketing of manufacturers?
· Pharmacy: a health care institution or store?
· Privatization of State-owned pharmacies
Contact:
Branislava Samardzic
+381 11 3333 008
09:00 – 10:00 Registration – coffee/tea
10:00 – 10:05 Opening remarks
Tomica Milosavljević, minister, Ministry of Health, Republic of Serbia
10:05-11:40 Panel 1: The pharmaceutical products market – from production to sales
· Effects of the economic crisis on the pharmaceutical products industry
· The pharmaceutical products marketed (manufacturer, distributer, retail) in Serbia vs. the region
· Regulatory framework and plans for improvement
· Political price of pharmaceutical products in Serbia
· Further consolidation of the market for the benefit of customers – manufacturers, wholesalers or pharmacies?
11:40 – 12:00 Morning networking break
12:10 – 13:30 Panel 2: Marketing pharmaceutical companies - a legitimate tool for conquering markets or channel for corruption?
· The role of marketing in pharmacy (where are the borders,..)
· Questions of ethics in relation to doctors and drug manufacturers
· Positive list - the system as protection from corruption
· Should pharmacy ethics, as a part of health care, be more important than profits?
· The role of wholesale in marketing medications –only a distribution channel or support for the marketing of manufacturers?
· Regulation in response to corruption
13:30 – 15:00 Panel 3: Pharmacies – part of the health care system or exclusively retail
· Good pharmacy practices
· Pharmacy: a health care institution or store?
· Pharmaceutical health care financing
· Equality of private and public pharmaceutical sectors
· Tax policy of the State towards the pharmaceutical sector
· Privatization of State-owned pharmacies
15:00 – 16:00 Networking lunch
Accommodation form [PDF 37 KB.].
Get your accommodation form HERE and send it to the fax number or e-mail address listed in the contact details below [PDF 37 KB.].